Edward J Unsworth

Title: Edward J Unsworth: Innovator in Vasoregulation and Human Physiology

Introduction

Edward J Unsworth is a notable inventor based in Kensington, MD (US). He holds a total of 6 patents that focus on advancements in the field of vasoregulation and human physiology. His work has significant implications for medical treatments, particularly in managing blood pressure and understanding cancer cell behavior.

Latest Patents

Unsworth's latest patents include innovative methods and compounds for regulating blood pressure in subjects. One of his key inventions involves the use of peptide AM(11-22) to reverse vasodilation of blood vessels. This vasoconstrictor can be utilized for various medical purposes, including hemostasis and the treatment of shock syndromes such as septic shock. Additionally, he has developed methods for reversing vasoconstriction by administering an inhibitor of AM(11-22) to reduce hypertension. His research also delves into the functional role of adrenomedullin (AM) in human pathology, demonstrating its expression in cancer cell lines and its function as a universal autocrine growth factor that drives neoplastic proliferation.

Career Highlights

Throughout his career, Edward J Unsworth has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Human Genome Sciences, Inc. His contributions to these institutions have been pivotal in advancing research in human health and disease.

Collaborations

Unsworth has collaborated with notable colleagues such as Alfredo Martinez and Mae Jean Miller. Their combined expertise has further enriched the research landscape in which Unsworth operates.

Conclusion

Edward J Unsworth's innovative contributions to vasoregulation and human physiology underscore his importance as an inventor in the medical field. His patents not only advance scientific understanding but also hold the potential for significant therapeutic applications.